Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients

Background: Although the Khorana venous thromboembolism (VTE) risk score (KRS) is well recognized as a simple VTE risk assessment method in patients with cancer, whether it is suitable for Asian populations is unclear. Objectives: This study validated KRS for the prediction of VTE and investigated t...

Full description

Bibliographic Details
Main Authors: Fumie Akasaka-Kihara, MD, Daisuke Sueta, MD, PhD, Masanobu Ishii, MD, PhD, MPH, Yuji Maki, MD, Kyoko Hirakawa, MD, PhD, Noriaki Tabata, MD, PhD, Miwa Ito, MD, PhD, Kenshi Yamanaga, MD, PhD, Koichiro Fujisue, MD, PhD, Tadashi Hoshiyama, MD, PhD, Shinsuke Hanatani, MD, PhD, Hisanori Kanazawa, MD, PhD, Seiji Takashio, MD, PhD, Yuichiro Arima, MD, PhD, Satoshi Araki, MD, PhD, Hiroki Usuku, MD, PhD, Taishi Nakamura, MD, PhD, Satoru Suzuki, MD, PhD, Eiichiro Yamamoto, MD, PhD, Hirofumi Soejima, MD, PhD, Koichi Kaikita, MD, PhD, Kenichi Matsushita, MD, PhD, Masao Matsuoka, MD, PhD, Koichiro Usuku, MD, PhD, Kenichi Tsujita, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:JACC: Asia
Subjects:
cancer
Khorana VTE risk score
mortality
risk stratification
venous thromboembolism
Online Access:http://www.sciencedirect.com/science/article/pii/S2772374721000752

Similar Items

Similar Items